The Biden administration is investing up to $24 million to develop messenger RNA-based (mRNA) platforms and technology aimed at more effectively fighting cancer and other diseases.
The administration’s new biomedical research agency, the Advanced Research Projects Agency for Health (ARPA-H), is providing the $24 million investment in the “Curing the Uncurable via RNA-Encoded Immunogene Tuning” (CUREIT) project, according to an Aug. 23 statement from the White House.